{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:15:38Z","timestamp":1765887338097},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T00:00:00Z","timestamp":1320710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00198-011-1823-7","type":"journal-article","created":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T04:12:41Z","timestamp":1320639161000},"page":"2135-2140","source":"Crossref","is-referenced-by-count":23,"title":["Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors"],"prefix":"10.1007","volume":"23","author":[{"given":"F.","family":"Douglas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. J.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Grey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,8]]},"reference":[{"key":"1823_CR1","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"P Sambrook","year":"2006","unstructured":"Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367:2010\u20132018","journal-title":"Lancet"},{"key":"1823_CR2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276\u20131287","journal-title":"Lancet"},{"key":"1823_CR3","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00198-008-0588-0","volume":"19","author":"ND Nguyen","year":"2008","unstructured":"Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19:1431\u20131444","journal-title":"Osteoporos Int"},{"key":"1823_CR4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","volume":"44","author":"JA Kanis","year":"2009","unstructured":"Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone 44:734\u2013743","journal-title":"Bone"},{"key":"1823_CR5","unstructured":"National Osteoporosis Foundation (2009) Clinician's guide to prevention and treatment of osteoporosis. http:\/\/www.nof.org\/sites\/default\/files\/pdfs\/NOF_ClinicianGuide2009_v7.pdf . Accessed 23 Jul 2011"},{"key":"1823_CR6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A (2008) Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 19:1395\u20131408","journal-title":"Osteoporos Int"},{"key":"1823_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.maturitas.2008.11.022","volume":"62","author":"J Compston","year":"2009","unstructured":"Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50\u00a0years in the UK. Maturitas 62:105\u2013108","journal-title":"Maturitas"},{"key":"1823_CR8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","volume":"47","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J (1999) Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47:555\u2013567","journal-title":"J Psychosom Res"},{"key":"1823_CR9","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11606-008-0772-0","volume":"23","author":"RA Yood","year":"2008","unstructured":"Yood RA, Mazor KM, Andrade SE, Emani S, Chan W, Kahler KH (2008) Patient decision to initiate therapy for osteoporosis; the influence of knowledge and beliefs. J Gen Intern Med 23:1815\u20131821","journal-title":"J Gen Intern Med"},{"key":"1823_CR10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(06)69394-X","volume":"368","author":"JE Compston","year":"2006","unstructured":"Compston JE, Seeman E (2006) Compliance with osteoporosis therapy is the weakest link. Lancet 368:973\u2013974","journal-title":"Lancet"},{"key":"1823_CR11","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00198-009-1141-5","volume":"21","author":"JT Schousboe","year":"2010","unstructured":"Schousboe JT, Dowd BE, Davison ML, Kane RL (2010) Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures. Osteoporos Int 21:1899\u20131909","journal-title":"Osteoporos Int"},{"key":"1823_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1300\/J013v31n01_02","volume":"31","author":"T Satterfield","year":"2000","unstructured":"Satterfield T, Johnson SM, Slovic P, Neil N, Schein JR (2000) Perceived risks and reported behaviors associated with osteoporosis and its treatment. Women Health 31:21\u201340","journal-title":"Women Health"},{"key":"1823_CR13","unstructured":"FRAX (2011) WHO fracture risk assessment tool. http:\/\/www.shef.ac.uk\/FRAX . Accessed 7 Sept 2011"},{"key":"1823_CR14","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1136\/bmj.320.7247.1446","volume":"320","author":"N Steel","year":"2000","unstructured":"Steel N (2000) Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. BMJ 320:1446\u20131447","journal-title":"BMJ"},{"key":"1823_CR15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7861\/clinmedicine.2-6-527","volume":"2","author":"PN Trewby","year":"2002","unstructured":"Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J (2002) Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. Clin Med 2:527\u2013533","journal-title":"Clin Med"},{"key":"1823_CR16","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1210\/jc.2009-2157","volume":"95","author":"MJ Bolland","year":"2010","unstructured":"Bolland MJ, Grey A (2010) Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines. J Clin Endocrinol Metab 95:1856\u20131860","journal-title":"J Clin Endocrinol Metab"},{"key":"1823_CR17","doi-asserted-by":"crossref","first-page":"d1140","DOI":"10.1136\/bmj.d1140","volume":"342","author":"R Moynihan","year":"2011","unstructured":"Moynihan R (2011) Overdiagnosis and the dangers of early detection. BMJ 342:d1140","journal-title":"BMJ"},{"key":"1823_CR18","doi-asserted-by":"crossref","first-page":"d2175","DOI":"10.1136\/bmj.d2175","volume":"342","author":"TLN Jarvinen","year":"2011","unstructured":"Jarvinen TLN, Sievanen H, Kannus P, Jokihaara J, Khan KM (2011) The true cost of pharmacological disease prevention. BMJ 342:d2175","journal-title":"BMJ"},{"key":"1823_CR19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00198-006-0294-8","volume":"18","author":"E Seeman","year":"2007","unstructured":"Seeman E, Compston J, Adachi J, Brandi ML, Cooper C, Dawson-Hughes B, Jonsson B, Pols H, Cramer JA (2007) Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int 18:711\u2013719","journal-title":"Osteoporos Int"},{"key":"1823_CR20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.327.7417.741","volume":"327","author":"G Gigerenzer","year":"2003","unstructured":"Gigerenzer G, Edwards A (2003) Simple tools for understanding risks: from innumeracy to insight. BMJ 327:741\u2013744","journal-title":"BMJ"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1823-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-011-1823-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1823-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:08:42Z","timestamp":1558609722000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-011-1823-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s00198-011-1823-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,8]]}}}